LeMaitre Vascular Inc.‘s board of directors decided to spike the Burlington peripheral vascular device maker’s employee stock purchasing plan, effective July 31, according to a filing with the federal Securities and Exchange Commission.
Under the terms of the plan, employees can buy stock in the company for 90 percent of its fair-market value and can elect to put up to 10 percent of their pay toward purchasing shares.
LeMaitre CFO J.J. Pellegrino did not immediately return a call for comment.